Compounds and methods for the targeted degradation of androgen receptor
Abstract:
This disclosure pertains to compounds, the preparation thereof, and the use of these compounds in the treatment of prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in subjects in need thereof.
Information query
Patent Agency Ranking
0/0